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Abstract
Background: Studies carried out in the community enable researchers to understand access to
medicines, affordability, and barriers to use from the consumer's point of view, and may stimulate
the development of adequate medicines policies. The aim of the present article was to describe
methodological and analytical aspects of quantitative studies on medicine utilization carried out at
the household level.
Methods:  Systematic review of original papers with data collected in studies in which the
household was a sampling unit, published between 1995 and 2008. The electronic review was
carried out in Medline/Pubmed, Scielo and Lilacs. The reference lists of the papers identified were
examined, as well as other publications by their authors. Studies on the utilization of specific
pharmacological groups, or those including only respondents with a given disease were excluded.
Results: Out of 4852 papers initially identified in the literature search, 61 fulfilled our inclusion
criteria. Most studies were carried out in Europe and North America and used a cross-sectional
approach. More than 80% used face-to-face interviews for data collection, and the most frequently
used recall period for assessing medicine utilization was 14–15 days. In 59% of the studies,
interviewers were trained to request the packaging of the medicines reported by the subjects;
medical prescriptions were requested less frequently (15% of the studies).
Conclusion: These data will be useful for updating researchers on what methods their peers are
currently using. Such information may help overcome challenges in the planning and analyses of
future studies. Moreover, this publication may contribute to the improvement of the quality of
medicine use data obtained in household surveys.
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Background
Studies on the overall prevalence of medicine utilization
are frequent in the scientific literature. Such studies are
characterized by the investigation of any medicine used
within a defined period of time. These studies represent
an important tool to be used in health system evalua-
tion.[1] Information may help draw conclusions about
prevalence of diseases, treatment of adverse events, health
status and quality of health care or of prescribers' behav-
ior.[2] Studies carried out in the community also enable
researchers to understand medicine use and its related
aspects from the consumer's point of view, and may stim-
ulate the development of adequate medicines policies.[3]
This type of study may also help in understanding access
to medicines, affordability, and barriers to use, at the com-
munity level.
In low and middle-income countries, in general, there are
no computerized systems that integrate the information
about medicines. Therefore, in most cases, it is not possi-
ble to carry out medicine utilization studies based on this
source of information. As a result, researchers usually rely
on studies with direct interviews with consumers, or
investigate medical records, which are often incomplete.
Taking into account that studies based on questionnaires
are subject to reporting bias, it is important to use a care-
fully designed methodology for data collection.
The primary aim of this review is to describe the method-
ologies used for collecting and analyzing quantitative data
on medicines use in household surveys. The paper also
analyzes qualitatively the methodologies employed in the
reviewed studies, and provides recommendations for
future studies in the field.
Methods
A literature review was carried out using the Pubmed, Sci-
elo and Lilacs databases. The following keywords were
searched in the title or abstract of the papers: "drug(s)
use", "drug(s) utilization", "drug(s) utilisation", "drug(s)
usage", "drug(s) consumption", "medication use", "med-
ication utilization", "medication usage", "medication
consumption", "medicine(s) use", "medicine usage",
"medicine consumption", "self-medication", "over-the-
counter".
Several restriction criteria were used in the electronic
search: (a) only articles published in Portuguese, English
and Spanish were considered (only four papers were
excluded due to this criterion); (b) only studies published
between January 1995 and June 2008 were included, in
order to focus on a description of the survey methods in
current use; (c) only original papers were included. Stud-
ies in hospitals, schools, universities, nurseries, pharmacy
counters, health clinics, and workplaces were excluded, as
well as those including only institutionalized individuals
(nursing homes and prisons). Finally, studies investigat-
ing the specific use of a given pharmacological group or
including only individuals with a given morbidity were
not considered.
Using the keywords mentioned earlier in Pubmed, 4852
titles were found until July 2005. After reviewing their
titles and abstracts, 134 original papers appeared to fulfill
the inclusion criteria, and therefore, their full texts were
obtained. From July 2005 to June 2008, the same search
strategy was automatically repeated in Pubmed. The
searches at Scielo and Lilacs added few publications, and
were made in July 2005, April 2006 and June 2008. Arti-
cles detected in the electronic search were reviewed by two
of the authors, who decided whether or not the manu-
script fulfilled the inclusion criteria. When they disagreed,
the article was discussed by the two until a final decision
was reached, based on the inclusion and exclusion crite-
ria.
The references of the selected papers were reviewed in
order to find other eligible publications. A search by the
names of all first authors from the selected papers was also
made. In seven cases, in which more than one publication
was based on the same data, only the first was included in
our review. After a detailed examination of the selected
papers (obtained in full), 61 fulfilled all inclusion criteria.
The original papers included in the review were classified
according to several characteristics:
- Country of data collection;
- Continent of data collection: studies carried out in more
than one continent were denominated 'mixed';
- Design used: cross-sectional, cross-sectional nested
within a longitudinal study, and longitudinal;
- Age groups: all ages, children only, adolescents and
adults, elderly only;
- Sample size: divided into ≤ 1000, 1001–5000, >5000
subjects;
- Sampling strategy: utilization of a random sampling
strategy or not;
- Questionnaire administration mode: face-to-face inter-
view, postal questionnaire, self-administration and tele-
phone;BMC Health Services Research 2008, 8:222 http://www.biomedcentral.com/1472-6963/8/222
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- Respondent: medicine user, medicine user and proxy,
medicine user and parents, parents only, family breadwin-
ner or any resident;
- Presentation of the survey questions that define the use
of medicines in the article: yes or no;
- Presentation of data on the validity of the questionnaire
used for evaluating medicine utilization: yes or no;
- Type of questions used to investigate medicine use: (a)
open ended questions (in general, the first question is:
"Have you used any medicine in the last xx days?" After a
positive answer, a second group of questions includes
identification and characterization of the medicines, fol-
lowing the specific objectives of the study); (b) checklists
(questions about specific medicine names, pharmacolog-
ical groups or diseases which are exclusively of interest to
the study).
- Request for packaging presentation: yes or no;
- Request for prescription presentation: yes or no;
- Types of medicines investigated: medicines for chronic
use, medicines for acute use or both;
- Indication of medicine taking: investigation of pre-
scribed, over-the-counter or both types of medicines;
- Pharmacological group classification: classification sys-
tem used for dividing medicines into pharmacological
groups;
- Denominator used in the analyses: individuals, medi-
cines or both;
- Recall period: as described in each article.
Results
Additional file 1 summarizes the 61 studies included in
our review, [4-64] whereas Additional files 2 and 3
present detailed characteristics of each article. Most stud-
ies were carried out in Europe and North America
(64.0%), and used cross sectional designs. Sample size
was greater than 1000 subjects in two-thirds of the stud-
ies, and most (95.1%) reported using random sampling
strategies. More than 80% used interviewers to collect
data. In the three studies including children,[32,49,62]
the information on medicine use was provided by par-
ents. In only 30% of the studies, the questions used to
define medicine utilization were presented in the publica-
tion; in 93.4%, authors did not provide information on
the validity of the questionnaire used to assess medicine
use. Approximately 75% of studies used open ended ques-
tions, 59% required the presentation of the medicine
packaging and only 15% required the presentation of
medical prescriptions. In 11.5% of studies, only medi-
cines for chronic illness were assessed, and 90% collected
information about medicines regardless of being pre-
scribed or not. The Anatomical Therapeutic Chemical
(ATC) was the most frequent pharmacological group clas-
sification system used, although 42.5% of the studies did
not indicate the classification system used. Most studies
used individuals as the denominator in the analyses.
The most frequently used recall period was 14 days, or two
weeks, although the periods ranged from one day to two
years (Figure 1). The recall period differed in studies inves-
tigating only medicines to treat chronic diseases (or for
regular use)[5,28,34,50,51,56,59] compared to those
evaluating medicines for acute use. The former usually
asked about current use without a defined reference
period. When both groups of medicines were investigated,
some studies differentiated the recall period for each kind
of medicine.[31,33,39,45,55]
Discussion
Data on past utilization of medicines that are collected by
interview may be inaccurate, since they are subject to
imprecise recall (leading to omission of medicines used),
incomplete information (for example, interviewees know-
ing the name of a medicine, but not the dose or duration
of the treatment) or even wrong information (due to mis-
understanding either the question itself or the medicine
treatment in use) [33,64]. As a consequence, some meth-
odological aspects are crucial for deriving valid informa-
tion on medicine use through household surveys.
The following sections discuss several key methodological
aspects of household surveys on medicine utilization,
summarizing the strategies used in the reviewed studies,
quantified in the results section, and presenting directions
and recommendations for future studies in the field.
1. Recall Period
One of the most important methodological aspects in
investigating medicine utilization through questionnaires
is the definition of the recall period to be used. There is no
consistency in the literature regarding the ideal recall
period to investigate medicine utilization. However, it is
known that the prevalence of medicine utilization is
extremely dependent on the recall period. For example,
two population-based studies carried out two years apart
in Pelotas, Brazil, using similar methodologies, found
prevalence of antimicrobial use in adults of 7.3% using a
recall period of 30 days, and of 5.4% using a recall period
of 15 days.[13] Another study carried out in Porto Alegre,
Brazil [65] collected information about medicine utiliza-
tion using two recall periods. The prevalence of medicineBMC Health Services Research 2008, 8:222 http://www.biomedcentral.com/1472-6963/8/222
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utilization 15 days prior to the interview was 54.5%, and
in the day before the interview, it was 35.5%.
The main methodological issue related to the choice of
the recall period is the difficulty in accurately remember-
ing and reporting use within the period. Van den Brandt
et al[66] showed that the accuracy of recall of used medi-
cines decreases with increasing age and with increasing
number of prescribed medicines taken, but the investiga-
tors did not find any recall differences between men and
women. In addition to the general problem of inaccurate
recall, a more serious problem can occur when two or
more groups to be compared have different levels of recall
accuracy. Sick people may report some variables (for
example, medicine use) more accurately than healthy
people.[55]
The main question to be answered when selecting recall
period is: to what extent it is reasonable for the sample of
respondents in this study to accurately recall details of
medicines taken for the period in question? Difficulty in
remembering is likely to be greater for longer period,[3]
but the prevalence of medicine utilization is also likely to
be greater due to accumulated medicine use during the
period.[41] However, longer periods may lead to underre-
porting of some types of medicine, leading to underesti-
mation of their use.[29,41]
Self-prescribed medicines are especially sensitive to diffi-
culty at remembering.[3] A study carried out in Que-
nia[67] showed 60% underreporting of self-prescribed
medicines when a two week recall period was used instead
of one day. Medicines used regularly, such as cardiovascu-
lar medicines, may be more easily and accurately recorded
using short recall periods.[27]
There is no ideal recall period for investigating medicine
utilization, because selection of recall period depends on
Distribution of the studies according to the recall period used Figure 1
Distribution of the studies according to the recall period used.
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what is to be recalled and ability of the respondent popu-
lation to remember. If the goal is to compare the data with
most studies in the literature, two weeks (14–15 days) is
the recommended period. There is a tendency in the liter-
ature that studies on acute illnesses use shorter recall peri-
ods in comparison to those on chronic illnesses.
2. Questionnaire administration
The procedure for administering the questionnaires (face-
to-face, telephone, mail interview or self-application) is
another important methodological aspect to be consid-
ered. A recent Brazilian study[4] about medicine utiliza-
tion in the retired population compared two approaches
for investigating medicine use: a postal self-completed
questionnaire and a household questionnaire completed
by interviewers. Response rates were twice as high in the
face-to-face approach. In Europe, studies[11,68,69]
reported postal response rates ranging from 71 to 92%; in
the United States, published studies reported response
rates as low as 60% [70] and 40% [71] for postal question-
naires.
In low and middle-income countries, telephone coverage
may be quite low, and studies using this approach are
likely to be affected by selection bias. High illiteracy rates,
also frequent in less developed countries, make self-
administration challenging. Finally, because response
rates are quite low for postal questionnaires, studies using
the face-to-face approach are recommended, particularly
in low and middle-income countries.
3. Questions used to assess medicine utilization
Other relevant questions for household surveys on medi-
cine utilization are the suitability of the terminology
used,[29] the clear definition of the "medicine use" varia-
ble[72] and the length of the questionnaire. In many situ-
ations, technical terminology cannot be understood by
the lay population, and particularly in settings with low
levels of formal education, simple terminology should be
used. The definition of what constitutes a medicine must
be clear, considering that some medicines such as analge-
sics, natural products, medicines for topical use may not
be reported by the respondents.[72]
In the study by Flores[27], it was noted that the level of
information about the medicine concept was low. The
interviewees frequently failed to report medicines to
reduce weight, allergies, pain, diarrhea, kidney or bladder
problems, digestive problems, colds or any kind of vita-
mins[27]. In terms of the length of the questionnaire, a
study by Acurcio[4] suggested that the length of the postal
questionnaire was one possible cause of low response
rate.
In summary, researchers should use simple, but techni-
cally correct terminology. Efforts should be made to state
clearly the definition of medicines to be used in the study,
and special attention should be paid to prompting
respondents for information about analgesics, natural
products, medicines for topical use, and others that they
may consider to be 'less important'.
4. Types of questions for investigating medicine utilization
Kimmel et al[73] studied the effect of reading a list of
medicines and the presentation of photos as a prompt to
recall the used medicines in a case-control study, which
resulted in a 6% increase in the previously recalled medi-
cines. Flores and Mengue,[27] studying overall medicine
utilization in the elderly, found a prevalence of 86% using
an open ended question, and 91% using a checklist.
Open ended questions are preferred for studies evaluating
overall medicine utilization. Checklists should be used
when authors are particularly interested in a given disease,
pharmacological group or specific medicine names. The
question(s) used for assessing medicine utilization
should be presented in the articles, so that other research-
ers can replicate the method in future studies. Unfortu-
nately, the majority of studies reviewed did not present
the main question used to assess medicine utilization.
5. Implications of using information provided by relatives 
or caregivers
Because most studies on medicine utilization include eld-
erly subjects, methodological attempts to improve the
accuracy of the information on medicine use are a prior-
ity. Medicine use of the elderly differs considerably from
other age groups.[74] The high number of medicines
used, hearing and visual impairments, and lack of mem-
ory may reduce the quality of the information given. More
serious morbidities may preclude direct interview. Some
studies decided to exclude the subjects not able to answer
the questionnaire.[13]
In order to minimize this problem, some researchers have
opted to interview close relatives or caregivers for the total
or partial collection of information about medicine utili-
zation.[75] In some situations, such information may be
more reliable and valid.[30] One should note that only
26.3% of the studies including only elderly subjects opted
to use this strategy. However, other publications may sim-
ply have failed to report this kind of information about
the data collection process.
Excluding elderly subjects without ability to answer a
questionnaire on medicine utilization will underestimate
the prevalence of medicine use, because these subjects are
more likely to have medicine utilization. Therefore, the
utilization of proxy information is recommended, partic-BMC Health Services Research 2008, 8:222 http://www.biomedcentral.com/1472-6963/8/222
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ularly in studies with elderly subjects. Finally, authors
should mention in the articles whether or not this strategy
was used, so that other researchers would be able to repli-
cate the methodology used, and correctly interpret the
findings of the study.
6. Packaging and prescription presentation
One way to validate the data on medicine utilization and
even to add recall about what was used in a specific period
is to ask for the medicine packaging. This strategy is par-
ticularly useful in household studies, where, medicines
tend to be stocked. As presented in Additional file 1, the
majority of the studies reviewed asked for the packaging
presentation. In some studies, the interviewees were asked
to show all the used medicines at the moment or in the
past. The interviewer had the task of selecting the eligible
medicines for the study. In other cases, the interviewers
asked only for the presentation of the medicines con-
cerned with the study.
The request to see prescriptions may also be used to vali-
date or qualify the data collected, because researchers may
be able to correctly identify the name and characteristics
of the medicines taken. In spite of its potential benefits,
this strategy was used in only 15% of the studies reviewed.
7. Medicines for regular use and medicines used 
occasionally
Most household surveys on medicine utilization investi-
gated medicines for treating both chronic and acute dis-
eases. However, characterization of what constitutes
regular use differs across studies. Some approaches are:
use of medicine habitually;[55] use of medicines on a reg-
ular basis or continuously;[39,45] current use;[16,31,33]
medicines used with fixed-time interval or for repetitive
disease occurrence;[51] medicines to chronic dis-
eases;[50] and medicines used regularly, without a date to
stop.[13]
Considering that the terminology used may affect the
interviewee's answer, it is important to clarify exactly what
is intended. For example, oral contraceptives are medi-
cines used regularly, but they are not used to treat chronic
diseases as the majority of the other medicines included in
this group.
Another issue to consider is the duration of time using a
medicine in order to it to be considered chronically or
habitually used. Some prophylactic treatments with anti-
biotics are long, but temporary. Should they be consid-
ered for chronic or acute use? In this sense, the utilization
of terms like "habitual" or "chronic" seem to be more
appropriate than the definition based on the number of
days in treatment. The term "without date to stop" may be
a useful alternative to differentiate the types of medicines.
8. Pharmacological group classification
When the study requires a classification into pharmaco-
logical groups, the quality of the information is a concern,
and presentation of the medicine packaging or prescrip-
tion is a useful practice.[76] Almost half of the reviewed
studies did not indicate the system used to classify the
medicines by pharmacological groups.
Many medicines have two or more indications; in order to
classify medicines into pharmacological groups, it is
essential to know which health problem the medicine was
used for. In the case of acetylsalicylic acid, for example,
the ATC code N02BA01 would identify use as an analge-
sic, while B01AC06 would identify use as a platelet aggre-
gation inhibitor.
There is no ideal system for classifying medicines into
pharmacological groups. However, it is extremely impor-
tant that authors mention the system chosen, in order to
allow comparisons across studies.
9. Denominators used in the analyses
Medicine utilization may be analyzed using either the
total number of subjects in the sample or the total number
of reported medicines as the denominator, which can lead
to very different conclusions about the prevalence of use
of different types of medicines. Some studies do not
inform about which kind of denominator was used in the
analyses, making it difficult to interpret the data or com-
pare across studies.
In studies of individual determinants of medicine utiliza-
tion, the denominator should be the number of subjects
in the sample. In studies on the characteristics of the med-
icines used, both approaches have been used. In the first
approach, each line in the database will correspond to a
subject, while in the second one, each line in the database
corresponds to a medicine used. This aspect was recently
discussed in a review paper.[72]
In studies of specific pharmacological groups, one may be
interested in reporting the prevalence of antimicrobial use
in the studied population (denominator = number of
individuals) or the proportion of antimicrobials in the
total number of medicines used in the sample (denomi-
nator = number of medicines).
In a study about utilization of generic medicines,[77]
both approaches resulted in very similar values; 3.9%
(over the total of medicines) and 3.6% (over the total of
subjects in the sample). However, this is not always the
case. Bertoldi et al. [13] found that 16.5% of the medi-
cines used were non-opioid analgesics. However, 32.2%
of the respondents used at least one non-opioid analgesic
in the period investigated. These findings show the impor-BMC Health Services Research 2008, 8:222 http://www.biomedcentral.com/1472-6963/8/222
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tance of the denominator in the interpretation of the stud-
ies, and highlight the need to state clearly which
denominator is used in each analysis.
Conclusion
The present review focused on the methods used in 61
household surveys of medicine utilization published
between January 1995 and June 2008. These data will be
useful for updating researchers on current standards of
practice, and may help overcome challenges in the plan-
ning and analyses of such studies. Moreover, recommen-
dations in this publication may help to improve the
quality of the data about medicine use obtained in house-
hold surveys.
Given that studies are conducted for different purposes, a
certain degree of heterogeneity in methods is expected.
However, standardization of certain practices would be
beneficial. For example, international and regional com-
parisons of medicine utilization prevalence would benefit
from the utilization of consistent methodologies. Actu-
ally, the World Health Organization has tried to overcome
the problem, by proposing standard instruments. In the
2002 World Health Survey, a standardized questionnaire
including some questions on medicine access, affordabil-
ity and use, was administered in 53 countries[78].
Regardless of the issue of standardization, some publica-
tions lack important details on the methodologies used,
for example, the system used to classify medicines into
pharmacological groups or the question used to investi-
gate the main outcome variable. Authors should provide
such details in the articles, so that other researchers may
adequately replicate studies in different settings. Finally,
because data on the reliability and validity of medicine
use questionnaires are rare, it is uncertain if the instru-
ments currently in use are accurately assessing the con-
struct of medicine utilization.
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